Model
Edge
Ra Pharmaceuticals, Inc.
0001481512
Filing type
8-K
Filing date
Apr 1, 2020
Updated
Apr 2, 2020 ยท 10:02 AM
Copy reference
Filing
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
Exhibits
EX-3.1
EXHIBIT 3.1
EX-3.2
EXHIBIT 3.2
EX-99.1
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic